ANI Pharmaceuticals Inc - Rentabilitas operasi ANIP

ANIP (ANI Pharmaceuticals Corp) - tandha merek perusahaan

ANI Pharmaceuticals remains resilient to economic downturns due to the demand for essential medications. The company is betting on rare pathologies and complex generics for expansion. Operating profit margins are illustrated by this chart from the GURU.Markets system, where 15.30 represents the latest metric level. Growth relies on line automation and the search for new formulas within R&D.

ANIP: Tingkat bathi operasi anipharmaceuticals.com 04.07.2022 - 19.11.2026

anipharmaceuticals.com - rincian analitis lan metrik utama (ANIP)

Analisis komprehensif perusahaan:ANI Pharmaceuticals Inc, ANIP
Barang utama ANI Pharmaceuticals

ANI Pharmaceuticals effectively combines the production of mass-market generics with the sale of high-cost orphan drugs, neutralizing price competition through exclusive niches. This indicator reflects the ratio of operating profit to revenue, demonstrating cost management efficiency and real business profitability, which allows the investor to assess the stability of the model through changes in core operating margins.

Pesaing utama

Rentabilitas operasi haleon.com|Rentabilitas operasi KVUE|Rentabilitas operasi Verona Pharma (VRNA)|Jyong Biotech (MENS) - Tingkat bathi adhedhasar bathi operasi|Margin operasi LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Rentabilitas operasi|PRGO - Rentabilitas operasi|Alvotech Corp (ALVO) - Margin dodolan operasi|LQDA: Margin operasi|Rentabilitas dodolan operasi glpg.com (GLPG)|Margin dodolan operasi MNKD|AMPH: Tingkat bathi operasi|Rentabilitas operasi pacira.com (PCRX)|Margin operasi ARS Pharma (SPRY)|Theravance Biopharma - Margin dodolan operasi|Rasio bathi operasi AQST (Aquestive Therapeutics)|SCPH: Margin dodolan operasi|Rentabilitas dodolan operasi Tectonic Therapeutic|TNXP: Margin operasi|SXT China (SXTC) - Margin operasi|Rentabilitas operasi eupraxiapharma.com|BioHarvest Sciences (BHST) - Rentabilitas kegiatan operasi|Rentabilitas operasi Invizyne (EXOZ)|ORMP - Rentabilitas dodolan operasi|Margin operasi ENTX (Entera Bio)|Tingkat bathi adhedhasar bathi operasi MindWalk Therapeutics|ABVC: Margin dodolan operasi|CPIX - Margin operasi|QNTM (Quantum BioPharma) - Margin dodolan operasi|Margin bathi operasi FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Margin operasi|Margin operasi ranitherapeutics.com|Rentabilitas operasi Synergy CHC Corp. (SNYR)|Rallybio Corp - Rentabilitas dodolan miturut bathi operasi|lexariabioscience.com - Margin dodolan operasi|Margin operasi Pulmatrix Inc PULM|Pheton Holdings - Margin operasi|Margin bathi operasi APM|Lyra Therapeutics, Inc. (LYRA) - Rentabilitas operasi|Rentabilitas dodolan operasi Impact BioMedical, Inc. (IBO)|Rentabilitas operasi TNF Pharma|YCBD: Tingkat bathi operasi|Margin operasi PRFX|CYTO - Rentabilitas dodolan operasi|Rentabilitas operasi Lipella LIPO|Rasio bathi operasi OPTN (OptiNose, Inc.)|PIRS - Rentabilitas operasi|Procaps (PROC) - Margin dodolan operasi|PTPI: Margin operasi|Qilian International (QLI) - Margin operasi|Rentabilitas operasi Acelyrin, Inc.|Margin operasi TFF Pharmaceuticals, Inc.